Cytokine regulation of intestinal epithelial cell proliferation

References

• Pinto D, Gregorieff A, Begthel H et al. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev.17(14), 1709–1713 (2003).
   PubMed Web of Science ®Google Scholar
• Kuhnert F, Davis CR, Wang HT et al. Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc. Natl Acad. Sci.USA101(1), 266–271 (2004).
   PubMed Web of Science ®Google Scholar
• Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell87(2), 159–170 (1996).
   PubMed Web of Science ®Google Scholar
• Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer1(1), 55–67 (2001).
   PubMed Web of Science ®Google Scholar
• Holmberg J, Genander M, Halford MM et al. EphB receptors coordinate migration and proliferation in the intestinal stem cell niche. Cell125(6), 1151–1163 (2006).
   PubMed Web of Science ®Google Scholar
• MacDonald TT. The gut is still the biggest lymphoid organ in the body. Mucosal Immunol.1, 246–247 (2008).
   Google Scholar
• Korzenik JR, Podolsky DK. Evolving knowledge and therapy of inflammatory bowel disease. Nat. Rev. Drug Discov.5(3), 197–209 (2006).
   PubMed Web of Science ®Google Scholar
• Packey CD, Sartor RB. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr. Opin. Infect. Dis.22(3), 292–301 (2009).
   PubMed Web of Science ®Google Scholar
• Rovedatti L, Kudo T, Biancheri P et al. Differential regulation of interleukin 17 and interferon g production in inflammatory bowel disease. Gut58(12), 1629–1636 (2009).
   PubMed Web of Science ®Google Scholar
• Monteleone G, Biancone L, Marasco R et al. Interleukin 12 is expressed and actively released by Crohn’s disease intestinal lamina propria mononuclear cells. Gastroenterology112(4), 1169–1178 (1997).
   PubMed Web of Science ®Google Scholar
• Monteleone G, Trapasso F, Parrello T et al. Bioactive IL-18 expression is up-regulated in Crohn’s disease. J. Immunol.163(1), 143–147 (1999).
   PubMed Web of Science ®Google Scholar
• Monteleone G, Monteleone I, Fina D et al. Interleukin-21 enhances T-helper cell type I signaling and Interferon-γ production in Crohn’s disease. Gastroenterology128(3), 687–694 (2005).
   PubMed Web of Science ®Google Scholar
• Fina D, Sarra M, Fantini MC et al. Regulation of gut inflammation and th17 cell response by interleukin-21. Gastroenterology134(4), 1038–1048 (2008).
   PubMed Web of Science ®Google Scholar
• Monteleone G, Caruso R, Fina D et al. Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Gut55(12), 1774–1804 (2006).
   PubMed Web of Science ®Google Scholar
• Caruso R, Fina D, Peluso I et al. A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3α, by gut epithelial cells. Gastroenterology132(1), 166–175 (2007).
   PubMed Web of Science ®Google Scholar
• Atreya R, Neurath MF. Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer. Curr. Drug Targets9(5), 369–374 (2008).
   PubMed Web of Science ®Google Scholar
• Fuss IJ, Heller F, Boirivant M et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J. Clin. Invest.113(10), 1490–1497 (2004).
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, D’Haens G, Hiele M et al. Appendectomy protects against ulcerative colitis. Gastroenterology106(5), 1251–1253 (1994).
   PubMed Web of Science ®Google Scholar
• Logan RF, Edmond M, Somerville KW et al. Smoking and ulcerative colitis. Br. Med. J. (Clin. Res. Ed.)288(6419), 751–753 (1984).
   PubMed Web of Science ®Google Scholar
• Franklin WA, McDonald GB, Stein HO et al. Immunohistologic demonstration of abnormal colonic crypt cell kinetics in ulcerative colitis. Hum. Pathol.16(11), 1129–1132 (1985).
   PubMed Web of Science ®Google Scholar
• Ierardi E, Principi M, Francavilla R et al. Epithelial proliferation and ras p21 oncoprotein expression in rectal mucosa of patients with ulcerative colitis. Dig. Dis. Sci.46(5), 1083–1087 (2001).
   PubMedGoogle Scholar
• Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment. Pharmacol. Ther.18(Suppl. 2), 1–5 (2003).
   PubMed Web of Science ®Google Scholar
• Nava P, Koch S, Laukoetter MG et al. Interferon-γ regulates intestinal epithelial homeostasis through converging β-catenin signaling pathways. Immunity32(3), 392–402 (2010).
   PubMed Web of Science ®Google Scholar
• Siegmund B, Fantuzzi G, Rieder F et al. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-γ and TNF-α production. Am. J. Physiol. Regul. Integr. Comp. Physiol.281(4), R1264–R1273 (2001).
   PubMed Web of Science ®Google Scholar
• Yoshihara K, Yajima T, Kubo C et al. Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice. Gut55(3), 334–341 (2006).
   PubMed Web of Science ®Google Scholar
• Dieleman LA, Ridwan BU, Tennyson GS et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology107(6), 1643–1652 (1994).
   PubMed Web of Science ®Google Scholar
• Ito R, Shin-Ya M, Kishida T et al. Interferon-γ is causatively involved in experimental inflammatory bowel disease in mice. Clin. Exp. Immunol.146(2), 330–338 (2006).
   PubMed Web of Science ®Google Scholar
• Mizoguchi E, Xavier RJ, Reinecker HC et al. Colonic epithelial functional phenotype varies with type and phase of experimental colitis. Gastroenterology125(1), 148–161 (2003).
   PubMedGoogle Scholar
• Vetuschi A, Latella G, Sferra R et al. Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats. Dig. Dis. Sci.47(7), 1447–1457 (2002).
   PubMed Web of Science ®Google Scholar
• Wright NA, Pike C, Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature343(6253), 82–85 (1990).
   PubMed Web of Science ®Google Scholar
• Higgins LM, Frankel G, Douce G et al.Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect. Immun.67(6), 3031–3039 (1999).
   PubMedGoogle Scholar
• Cliffe LJ, Humphreys NE, Lane TE et al. Accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion. Science308(5727), 1463–1465 (2005).
   PubMed Web of Science ®Google Scholar
• Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat. Rev. Immunol.2(9), 647–655(2002).
   PubMed Web of Science ®Google Scholar
• Wright N, Watson A, Morley A et al. Cell kinetics in flat (avillous) mucosa of the human small intestine. Gut14(9), 701–710 (1973).
   PubMedGoogle Scholar
• Iwamoto M, Koji T, Makiyama K et al. Apoptosis of crypt epithelial cells in ulcerative colitis. J. Pathol.180(2), 152–159 (1996).
   PubMed Web of Science ®Google Scholar
• Cadigan KM. Wnt-β-catenin signaling. Curr. Biol.18(20), R943–R947 (2008).
   Web of Science ®Google Scholar
• Procaccino F, Reinshagen M, Hoffmann P et al. Protective effect of epidermal growth factor in an experimental model of colitis in rats. Gastroenterology107(1), 12–17 (1994).
   PubMed Web of Science ®Google Scholar
• Greenwood-Van Meerveld B, Venkova K, Connolly K. Efficacy of repifermin (keratinocyte growth factor-2) against abnormalities in gastrointestinal mucosal transport in a murine model of colitis. J. Pharm. Pharmacol.55(1), 67–75 (2003).
   PubMedGoogle Scholar
• Zhao J, de Vera J, Narushima S et al. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice. Gastroenterology132(4), 1331–1343 (2007).
   PubMed Web of Science ®Google Scholar
• Reinisch W, de Villiers W, Bene L et al. Fontolizumab in moderate to severe Crohn’s disease: a Phase 2, randomized, double-blind, placebo-controlled, multiple-dose study. Inflamm. Bowel Dis.16(2), 233–242 (2010).
   PubMed Web of Science ®Google Scholar